SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Livingston S., Comprehensive management of epilepsy in infancy, childhood, and adolescence. Springfield , IL : Charles C Thomas, 1972.
  • 2
    Freeman JM, Kelly MT, Freeman JB, The epilepsy diet treatment: an introduction to the ketogenic diet. New York : Demos Vermande, 1996.
  • 3
    Nebeling LC, Lerner E., Implementing a ketogenic diet based on medium-chain triglyceride oil in pediatric patients with cancer. J Am Diet Assoc 1995;95:6937.
  • 4
    Sperl W., [Diagnosis and therapy of mitochondriopathies.] [German] Wien Klin Wochenschr 1997;109:939.
  • 5
    Swoboda KJ, Specht L, Jones HR, Shapiro F, DiMauro S, Korson M., Infantile phosphofructokinase deficiency with arthrogryposis: clinical benefit of a ketogenic diet. J Pediatr 1997;131:9324.
  • 6
    Klepper J, Wang D, Fischbarg J, et al. Defective glucose transport across brain tissue barriers: a newly recognized neurological syndrome. Neurochem Res 1999;24:58794.
  • 7
    Carroll J, Koenigsberger D., The ketogenic diet: a practical guide for caregivers. J Am Diet Assoc 1998;98:31621.
  • 8
    Huttenlocher PR, Ketonemia and seizures: metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsy. Pediatr Res 1976;10:53640.
  • 9
    Bough KJ, Eagles DA, A ketogenic diet increases the resistance to pentylenetetrazole-induced seizures in the rat. Epilepsia 1999;40:13843.
  • 10
    Trauner DA, Medium-chain triglyceride diet in intractable seizure disorders. Neurology 1985;35:2378.
  • 11
    Schwartz RH, Eaton J, Bower BD, Aynsley-Green A., Ketogenic diets in the treatment of epilepsy: short-term clinical effects. Dev Med Child Neurol 1989;31:14551.
  • 12
    Schwartz RH, Boyes S, Aynsley-Green A., Metabolic effects of three ketogenic diets in the treatment of severe epilepsy. Dev Med Child Neurol 1989;31:15260.
  • 13
    Woody RC, Brodie M, Hampton DK, Fiser RH Jr. Corn oil ketogenic diet for children with intractable seizures. J Child Neurol 1988;3:214.
  • 14
    Agostoni C, Trojan S, Bellu R, Riva E, Giovannini M., Neurodevelopmental quotient of healthy term infants at 4 months and feeding practice: the role of long-chain polyunsaturated fatty acids. Pediatr Res 1995;38:2626.
  • 15
    Farquharson J, Jamieson EC, Logan RW, Patrick WJ, Howatson AG, Cockburn F., Age- and dietary-related distributions of hepatic arachidonic and docosahexaenoic acid in early infancy. Pediatr Res 1995;38:3615.
  • 16
    Emmison N, Gallagher PA, Coleman RA, Linoleic and linolenic acids are selectively secreted in triacylglycerol by hepatocytes from neonatal rats. Am J Physiol 1995;269:R806.
  • 17
    Appleton DB, DeVivo DC, An animal model for the ketogenic diet. Epilepsia 1974;15:21127.
  • 18
    Nakazawa M, Kodama S, Matsuo T., Effects of ketogenic diet on electroconvulsive threshold and brain contents of adenosine nucleotides. Brain Dev 1983;5:37580.
  • 19
    Hori A, Tandon P, Holmes GL, Stafstrom CE, Ketogenic diet: effects on expression of kindled seizures and behavior in adult rats. Epilepsia 1997;38:7508.
  • 20
    Millichap JG, Jones JD, Rudis BP, Mechanism of anticonvulsant action of ketogenic diet. Am J Dis Child 1964;107:593604.
  • 21
    Uhlemann ER, Neims AH, Anticonvulsant properties of the ketogenic diet in mice. J Pharmacol Exp Ther 1972;180:2318.
  • 22
    Mahoney AW, Hendricks DG, Bernhard N, Sisson DV, Fasting and ketogenic diet effects on audiogenic seizures: susceptibility of magnesium deficient rats. Pharmacol Biochem Behav 1983;18:6837.
  • 23
    Otani K, Yamatodani A, Wada H, Mimaki T, Yabuuchi H., [Effect of ketogenic diet on the convulsive threshold and brain amino acid and monoamine levels in young mice.] [Japanese] No to Hattatsu [Brain Dev] 1984;16:196204.
  • 24
    Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993;123:193951.
  • 25
    US Department of Agriculture, Agricultural Research Service. USDA Nutrient Database for Standard Reference. Release 13, 1999. Nutrient Data Laboratory Home Page, http://www.nal.usda.govfnicfoodcomp.
  • 26
    Williamson DH, Mellanby J, Krebs HA, Enzymatic determination of D(–)-β-hydroxybutyric acid and acetoacetic acid in blood. Biochem J 1962;82:906.
  • 27
    Krall RL, Penry JK, White BJ, Kupferberg HJ, Swinyard EA, Antiepileptic drug development. II. Anticonvulsant drug screening. Epilepsia 1978;19:40928.
  • 28
    Crozier G, Bois-Joyeux B, Chanez M, Girard J, Peret J., Metabolic effects induced by long-term feeding of medium-chain triglycerides in the rat. Metabolism 1987;36:80714.
  • 29
    Robinson AM, Williamson DH, Physiological roles of ketone bodies as substrates and signals in mammalian tissues. Physiol Rev 1980;60:14387.
  • 30
    Quant PA, Robin D, Robin P, Ferré P, Brand MD, Girard J., Control of hepatic mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase during the foetal/neonatal transition, suckling and weaning in the rat. Eur J Biochem 1991;195:44954.
  • 31
    Hegardt FG, Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase: a control enzyme in ketogenesis. Biochem J 1999;338:56982.
  • 32
    Cullingford TE, Dolphin CT, Bhakoo KK, Peuchen S, Canevari L, Clark JB, Molecular cloning of rat mitochondrial 3-hydroxy-3-methylglutaryl-CoA lyase and detection of the corresponding mRNA and of those encoding the remaining enzymes comprising the ketogenic 3-hydroxy-3-methylglutaryl-CoA cycle in central nervous system of suckling rat. Biochem J 1998;329:37381.
  • 33
    Casals N, Roca N, Guerrero M, et al. Regulation of the expression of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene: its role in the control of ketogenesis. Biochem J 1992;283:26164.
  • 34
    Gjedde A, Crone C., Induction processes in blood-brain transfer of ketone bodies during starvation. Am J Physiol 1975;229:11659.
  • 35
    Drewes LR, Gerhart DZ, Leino RL, Enerson BE, Astrocyte foot processes and blood-brain transport. In: LeeTJF, PearceWJ, eds. XVIIIth International Symposium on Cerebral Blood Flow and Metabolism, Williamsburg, Va, 1997: 40.
  • 36
    Leino RL, Gerhart DZ, Drewes LR, Monocarboxylate transporter (MCT1) abundance in brains of suckling and adult rats: a quantitative electron microscopic immunogold study. Dev Brain Res 1999;113:4754.
  • 37
    Koranyi L, Bourey RE, James D, Mueckler M, Fiedorek FT Jr, Permutt MA, Glucose transporter gene expression in rat brain: pretranslational changes associated with chronic insulin-induced hypoglycemia, fasting, and diabetes. Mol Cell Neurosci 1991;2:24452.
  • 38
    Nehlig A., Cerebral energy metabolism, glucose transport and blood flow: changes with maturation and adaptation to hypoglycaemia. Diabetes Metab 1997;23:1829.
  • 39
    DeVivo DC, Leckie MP, Ferrendelli JS, McDougal DB Jr. Chronic ketosis and cerebral metabolism. Ann Neurol 1978;3:3317.
  • 40
    Janigro D., Blood-brain barrier, ion homeostasis and epilepsy: possible implications towards the understanding of ketogenic diet mechanisms. Epilepsy Res 1999;37:22332.
  • 41
    Cahill GF, Starvation. Trans Am Clin Climatol Assoc 1982;94:121.
  • 42
    Seaton TB, Welle SL, Warenko MK, Campbell RG, Thermic effect of medium-chain and long-chain triglycerides in man. Am J Clin Nutr 1986;44:6304.
  • 43
    Bough KJ, Fetner JD, Eagles DA, A ketogenic diet exacerbates kainate-induced seizures in the rat. Soc Neurosc Abstr 1998;24:1208.
  • 44
    Thavendiranathan P, Mendonca A, Dell C, et al. The MCT ketogenic diet: effects on animal seizure models. Exp Neurol 2000;161:696703.
  • 45
    Browning RA, Nelson DK, Modification of electroshock and pentylenetetrazol seizure patterns in rats after precollicular transections. Exp Neurol 1986;93:54656.
  • 46
    Newall CA, Anderson LA, Phillipson JD, Evening primrose monograph. In: NewallCA, AndersonLA, PhillipsonJD, eds. Herbal medicines: a guide for health-care professionals. London : Pharmaceutical Press, 1997:1103.
  • 47
    Matthews PJ, Bough KJ, Eagles DA, A ketogenic diet markedly exacerbates seizure severity but elevates seizure threshold in the same animals. Epilepsia 1998;39(suppl 6):45.
  • 48
    Wasterlain CG, Shirasaka Y., Seizures, brain damage and brain development. Brain Dev 1994;16:27995.
  • 49
    Neville BG, Reversible disability associated with epilepsy. Brain Dev 1999;21:825.
  • 50
    Likhodii SS, Cunnane SC, Utilization of carbon from dietary polyunsaturates for brain cholesterol synthesis during early postnatal development in the rat: a 13C NMR study, Magn Reson Med 1995; 34:80313.
  • 51
    Menard CR, Goodman KJ, Corso TN, Brenna JT, Cunnane SC, Recycling of carbon into lipids synthesized de novo is a quantitatively important pathway of alpha-[U-13C]linolenate utilization in the developing rat brain, J Neurochem 1998;71:21518.
  • 52
    Yehuda S, Carasso RL, Mostofsky DI, Essential fatty acid preparation (SR-3) raises the seizure threshold in rats. Eur J Pharmacol 1994;254:1938.
  • 53
    Vreugdenhil M, Bruehl C, Voskuyl RA, Kang JX, Leaf A, Wadman WJ, Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons. Proc Natl Acad Sci USA 1996;93:1255963.
  • 54
    Voskuyl RA, Vreugdenhil M, Kang JX, Leaf A., Anticonvulsant effect of polyunsaturated fatty acids in rats, using the cortical stimulation model. Eur J Pharmacol 1998;341: 14552.